Phase III Randomized Study of Sorafenib Plus Doxorubicin Versus Sorafenib in Patients with Advanced Hepatocellular Carcinoma (HCC)
http://clinicaltrials.gov/ct2/show/NCT01004978
Contact our study research associate Ismael Castaneda MD at 973-972-6812 or call myself at 973-972-0607 for more information
http://clinicaltrials.gov/ct2/show/NCT01004978
Contact our study research associate Ismael Castaneda MD at 973-972-6812 or call myself at 973-972-0607 for more information